Physician profile
Stephen Cohen
NPI 1225031586
$5,982.88
in general payments reported to CMS, 2019-2025
33 companies · $58.14 in 2025
The $58.14 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,135 · 2020: $711 · 2021: $590 · 2022: $1,049 · 2023: $1,449 · 2024: $991 · 2025: $58.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,468 · Education: $29.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,467.97 |
| Education | $29.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $850.69 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $615.27 | 2021-2024 | |
| Medtronic, INC. | $557.96 | 2021-2024 | Corevalve Evolut R, Linq II, Azure Xt Dr Mri Surescan |
| Merz North America, INC. | $530.53 | 2019-2025 | |
| Medtronic Vascular, INC. | $449.73 | 2019 | |
| Amgen INC. | $414.52 | 2019-2023 | Repatha |
| Merck Sharp & Dohme LLC | $333.56 | 2021-2024 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $267.69 | 2023-2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $261.82 | 2020-2024 | Camzyos, Eliquis |
| Novo Nordisk INC | $233.61 | 2022-2024 | Ozempic, Wegovy |
| Astellas Pharma US INC | $214.99 | 2020 | |
| Abbott Laboratories | $168.05 | 2021-2024 | Cardiomems, Navitor, Jot Dx |
| Pfizer INC. | $165.97 | 2023-2024 | |
| Biotronik INC. | $154.55 | 2019-2020 | |
| Boston Scientific Corporation | $99.64 | 2019-2024 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $88.86 | 2021-2022 | |
| Impulse Dynamics (USA) INC. | $77.64 | 2022-2023 | Optimizer |
| Kiniksa Pharmaceuticals, LTD. | $65.64 | 2021-2022 | |
| Heartflow, INC. | $48.91 | 2023 | Ffrct |
| Cardiva Medical, INC. | $48.02 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Abiomed | $47.36 | 2024 | Impella |
| Esperion Therapeutics, INC. | $42.89 | 2021-2024 | Nexletol |
| Astrazeneca Pharmaceuticals LP | $41.70 | 2023 | Wainua, Farxiga |
| Kestra Medical Technology Services, INC. | $25.76 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $23.54 | 2024 | Arcalyst |
| Scpharmaceuticals INC. | $22.72 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.40 | 2024 | |
| Lexicon Pharmaceuticals, INC. | $21.01 | 2023 | Inpefa |
| Regeneron Healthcare Solutions, INC. | $18.99 | 2023 | Evkeeza |
| Sanofi Pasteur INC. | $18.63 | 2022 | |
| Recor Medical INC | $18.23 | 2024 | Paradise Renal Denervation System |
| Alnylam Pharmaceuticals INC. | $17.59 | 2021 | |
| Gilead Sciences, INC. | $14.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.